2025-04-05 01:32:42
Latest Post
Sai Life Sciences sets up Peptide Research Center in India
Netweb Technologies Ltd receives PLI Incentive Under IT Hardware Scheme 2.0
BHEL signs contract for ± 800 kV, 6000 MW Bhadla-Fatehpur LCC HVDC Terminal Station along with AC Transmission at Bhadla and Fatehpur
DEE Development Engineers Limited receives order worth approx. Rs. 55 crores- SURATWWALA BUSINESS GROUP Ltd purchases new commercial office space
Stock Report
Lyka Labs Ltd posts Rs. 3 crore consolidated loss in Q4FY23
Posted On : 2023-05-23 18:31:22( TIMEZONE : IST )
Lyka Labs Limited has reported Consolidated financial results for the period ended March 31, 2023.
Financial Results (Q4 FY2023) - QoQ Comparison
The company has reported total income of Rs. 22.6674 crores during the period ended March 31, 2023 as compared to Rs. 18.8803 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs. -3.0074 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. -10.4159 crores for the period ended December 31, 2022.
The company has reported EPS of Rs. -1.05 for the period ended March 31, 2023 as compared to Rs. -3.64 for the period ended December 31, 2022.
| Financials | Q4 FY2023 | Q3 FY2023 | % Change |
| Total Income | ₹22.6674 crs | ₹18.8803 crs |  20.06% |
| Net Profit | ₹-3.0074 crs | ₹-10.4159 crs |  71.13% |
| EPS | ₹-1.05 | ₹-3.64 | 71.15% |
Financial Results (Q4 FY2023) - YoY Comparison
The company has reported total income of Rs.22.6674 crores during the period ended March 31, 2023 as compared to Rs.35.7182 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs.-3.0074 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.-15.0698 crores for the period ended March 31, 2022.
The company has reported EPS of Rs.-1.05 for the period ended March 31, 2023 as compared to Rs.-5.26 for the period ended March 31, 2022.
| Financials | Q4 FY2023 | Q4 FY2022 | % Change |
| Total Income | ₹22.6674 crs | ₹35.7182 crs |  -36.54% |
| Net Profit | ₹-3.0074 crs | ₹-15.0698 crs | 80.04% |
| EPS | ₹-1.05 | ₹-5.26 | 80.04% |
Financial Results (Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.96.4738 crores during the Financial Year ended March 31, 2023 as compared to Rs.196.1791 crores during the Financial Year ended March 31, 2022.
The company has posted net profit / (loss) of Rs.-13.2118 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.38.9998 crores for the Financial Year ended March 31, 2022.
The company has reported EPS of Rs.-4.63 for the Financial Year ended March 31, 2023 as compared to Rs.13.57 for the Financial Year ended March 31, 2022.
| Financials | Year Ended FY2023 | Year Ended FY2022 | % Change |
| Total Income | ₹96.4738 crs | ₹196.1791 crs | -50.82% |
| Net Profit | ₹-13.2118 crs | ₹38.9998 crs | -133.88% |
| EPS | ₹-4.63 | ₹13.57 | -134.12% |
Shares of Lyka Labs Limited was last trading in BSE at Rs. 94.50 as compared to the previous close of Rs. 97.15. The total number of shares traded during the day was 11238 in over 298 trades.
The stock hit an intraday high of Rs. 97.15 and intraday low of 90.00. The net turnover during the day was Rs. 1074865.00.
